Alterations of methylation levels occurring in the promoter of the human MYOD1 gene have been reported in RMS tumours, with partially methylated MYOD1 up-stream regions present essentially in ERMS subtypes [33]. The gene discussed is MYOD1; the disease is embryonal rhabdomyosarcoma.